- Letter to the Editor
- Open access
- Published:
Correspondence on adverse conditions of COVID-19 vaccination
The Egyptian Journal of Internal Medicine volume 35, Article number: 33 (2023)
Dear Editor,
We would like to comment on the article An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19 [1]. Muslim et al. reviewed the literature and collected data from 15 studies, totaling 22 cases of fatal adverse condition/death associated with COVID-19 vaccination [1]. According to Muslim et al., an analysis of these data shows that many of those who died (40.90%) were previously healthy people. Within 3 weeks of vaccination, all of those who died developed symptoms or were admitted to the hospital. 86.36% of deaths occurred within 3 weeks of vaccination/presentation/admission/intervention [1]. Muslim et al. concluded that knowledge of fatal adverse conditions in the temporal association of vaccination will aid in dealing with these situations and further improving the safety of the vaccination drive [1].
We both concur that there may be a sizable fatality rate associated with cerebral venous sinus thrombosis brought on by the COVID-19 vaccination. A fascinating clinical problem is the unfavorable reaction to COVID-19 immunization. Although case-specific data can be included in articles, there is no way to prove conclusively how confounding variables affect the results [2]. Finding the right answer could be challenging. The current research reads like an investigation of the impacts of vaccine aversion and has a very subjective appearance. Finding the precise reason for a vaccination reaction may be challenging due to a paucity of clinical data describing the physiological and immunological status of COVID-19 vaccine recipients prior to vaccine injection. Even when they do exist, comorbidities are rarely mentioned in clinical records. Determining the precise patho-immuno-pharmacological link can be difficult at times due to a lack of expertise. It may be difficult to comprehend how concurrent medical issues influence clinical outcomes [3]. The genetic influences are the least important [4]. More specifics are difficult to provide when none of the current report’s conclusions is supported by new data.
References
Muslim S, Mustafa G, Nasrin N, Firdaus A, Singh SK (2023) An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19. Egypt J Intern Med 35(1):11
Deniz A, Alikılıç D, Öztürk M, Karaca Ö, Güngör M, Kara B (2023) Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome. J AAPOS S1091–8531(23):00012–5. https://doi.org/10.1016/j.jaapos.2022.12.001. (Online ahead of print)
Mungmunpuntipantip R, Wiwanitkit V (2021) Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clin Appl Thromb Hemost 27:10760296211060446
Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M (2022) GNB3 c825c.>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet 13:932043
Author information
Authors and Affiliations
Contributions
AK 50 % ideas, writing, analyzing, approval for submission. VW 50 % ideas, supervision, approval for submission. The authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kleebayoon, A., Wiwanitkit, V. Correspondence on adverse conditions of COVID-19 vaccination. Egypt J Intern Med 35, 33 (2023). https://doi.org/10.1186/s43162-023-00211-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43162-023-00211-6